AGS-1C4D4: Clinical Trials

2 trials of AGS-1C4D4, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow AGS-1C4D4: new trials by email Literature Review of AGS-1C4D4 trials Research Report on AGS-1C4D4

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
AGS-1C4D4, gemcitabine - Pancreatic Cancer, Carcinoma, Pancreatic Ductal
Phase 2CompletedAgensys, Inc.22012-08-072017-05-16
A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
AGS-1C4D4, Gemcitabine - Carcinoma, Pancreatic Ductal, Pancreatic Cancer
Phase 2CompletedAstellas Pharma Inc2052009-04-012015-09-14

Conditions studied

Carcinoma, Pancreatic Ductal (2)  ·  Pancreatic Diseases (2)  ·  Pancreatic Neoplasms (2)

Sponsors

Agensys, Inc. (1)  ·  Astellas Pharma Inc (1)

Countries

Canada (2)  ·  United States (2)  ·  France (1)  ·  Russia (1)  ·  Spain (1)

NIH funding

2009 (1)